Availability and funding of clinical genomic sequencing globally
A useful review on the current situation:
Our case studies, based on published and unpublished literature as well as discussions with key experts in each country, are illustrative of three types of funding systems:
Publicly funded/national system: UK, which is one of a few countries with national, government-based funding for NGS (others include Belgium, Denmark, the Netherlands and Australia).
Publicly funded/provincial system: Canada, for which public funding of tests is provided at the provincial level after approval based on meeting specific criteria.
Mixed private/public system: USA, which has variable private and public insurer coverage.
The 4 steps: